---
title: Vaccination may be the answer to JAK inhibitor-associated shingles risk, but
  its safety in RA remains in question
image: images/writing/post-51.jpg
link: https://www.pharmaceutical-technology.com/comment/vaccination-shingrix/
categories:
- Analyst Insight
- Rheumatology
- Conference Review

---
